Single, extrinsic, environmentally sensitive fluorophores can be used to quantitate formation of protein-protein complexes. These can be prepared semi-synthetically by covalent coupling to single cysteine mutations introduced at positions where the fluorophore is predicted to respond to formation of the complex without adversely affecting the interaction. The three-dimensional structure of a proteinprotein interface can be used to select such locations by identifying residues that are located at the edge of a buried interfacial region, and are in partial steric contact with both partners as indicated by a change in their static solvent-accessible surface area upon complex formation. Using this design approach, cysteine mutations were introduced into the B1 domain of protein G, which successfully monitor complex formation with minimal interference. Such constructs have great utility in the analysis of solution properties of interface mutants. Keywords: B1 domain/environmentally sensitive fluorophores/ IgG-binding proteins/protein-protein interactions/structurebased design Introduction Specific protein-protein interactions play a critical role in a wide variety of processes. A quantitative description of such interactions is necessary to elucidate the mechanism by which protein-protein interfaces are formed and to understand how these participate in the control of biological processes (Phizicky and Fields, 1995) . Fluorescence techniques provide sensitive, quantitative probes for monitoring complex formation in solution (Brown and Royer, 1997). The interaction can be monitored by measuring the change of either fluorescence resonance energy transfer between a donor-acceptor pair (Clegg, 1995) , or of the intrinsic fluorescence of a single fluorophore (Guiliano and Post, 1995) . Here we show how a detailed three-dimensional structure of a protein-protein interface can be used to identify locations where single cysteine mutations can be constructed in one protein for covalent attachment of environmentally sensitive fluorophores that respond to formation of the complex without adversely affecting the interaction.
Introduction
Specific protein-protein interactions play a critical role in a wide variety of processes. A quantitative description of such interactions is necessary to elucidate the mechanism by which protein-protein interfaces are formed and to understand how these participate in the control of biological processes (Phizicky and Fields, 1995) . Fluorescence techniques provide sensitive, quantitative probes for monitoring complex formation in solution (Brown and Royer, 1997) . The interaction can be monitored by measuring the change of either fluorescence resonance energy transfer between a donor-acceptor pair (Clegg, 1995) , or of the intrinsic fluorescence of a single fluorophore (Guiliano and Post, 1995) . Here we show how a detailed three-dimensional structure of a protein-protein interface can be used to identify locations where single cysteine mutations can be constructed in one protein for covalent attachment of environmentally sensitive fluorophores that respond to formation of the complex without adversely affecting the interaction.
Intrinsic fluorescence changes are critically dependent on the location of the fluorophore which has to be positioned in a region where the microenvironment changes with formation of the complex. The fluorophore should therefore be placed either in the protein-protein interface itself, or in a region that undergoes a local conformational change upon complex formation. Intrinsic tryptophan fluorescence can be a good probe, but naturally occurring tryptophans may either not be positioned appropriately, or their signal can be obscured by the fluorescence of other, non-responsive tryptophans. These problems can be circumvented by introducing extrinsic, covalently conjugated fluorophores with unique fluorescence characteristics (Hermanson, 1996) . Correct placement of such a probe can be problematic. Indiscriminate derivatization of surface residues partially defeats the aim of introducing single reporter groups and may also disrupt binding. Introduction of cysteine mutations to provide unique attachment points requires additional structural or biochemical information about the interface, or the construction of multiple mutants to scan likely candidate positions. With the increasing availability of highresolution structures of protein-protein complexes (Jones and Thornton, 1996) , it is now possible to use a structure-based design approach to place fluorescent reporter groups in critical positions to study the detailed mechanisms of complex formation. We have chosen to study the interaction between the 56-residue B1 domain of Streptococcal protein G (GB1) (Boyle, 1990; Goward et al., 1993) and the constant domain fragment of human immunoglobulin IgG (hFc) by engineering single cysteine mutations in GB1 for attachment of fluorescent reporter groups. The high-resolution structure of a complex of this protein with hFc (Sauer-Eriksson et al., 1995) was used to identify locations at the edge of a surface patch that forms the protein-protein interface for site-specific attachment of environmentally sensitive fluorophores that monitor complex formation with minimal interference.
Many Staphylococcal and Streptococcal strains display proteins on their extracellular surface, that bind to a variety of proteins in the serum of the infected host (Boyle, 1990) . Although the biological function of these proteins remains unclear, it has been suggested that a coating of host proteins aids the pathogen in evading the host immune response (Goward et al., 1993) . These proteins consist of small, independent domains, each specific for a subset of serum proteins. GB1 has high affinity for a wide spectrum of IgG subclasses across many species (Boyle, 1990) . The GB1 domain has been cloned (Fahnestock et al., 1986) , is readily produced by highlevel over-expression in Escherichia coli (Minor and Kim, 1994) and is used in numerous biotechnological and immunological applications (Ståhl et al., 1993) . The structure of the isolated GB1 domain has been extensively characterized by NMR (Gronenborn et al., 1991; Lian et al., 1992) and X-ray crystallography (Achari et al., 1992; Gallagher et al., 1994) , and shown to consist of a four-stranded β-sheet, stabilized by a single α-helix. There are two GB1 binding sites on the surface of an IgG molecule, located on the Fab and Fc fragments respectively (Björck and Kronvall, 1984; Stone et al., 1989) . The structures of both complexes have been determined to high resolution by X-ray crystallography Wigley, 1992, 1994; Sauer-Eriksson et al., 1995) , and found to involve two completely different interfaces on the surface of GB1. The interaction with the constant region of the Fab fragment is mediated primarily by main-chain hydrogen bonds between one of the edge strands of the GB1 β-sheet with a β-sheet of the Fab, thereby forming an extended β-sheet that spans the interface Wigley, 1992, 1994) . At the other site, which lies in the interface between the C H 2-C H 3 region of the hFc fragment, the interactions are mediated primarily by residue side-chains on a surface of GB1 that fills the region between one side of the α-helix and β-sheet Wigley, 1992, 1994; Sauer-Eriksson et al., 1995) . This interface is unusual in that it is composed primarily of buried hydrophilic residues (Jones and Thornton, 1996) . The contribution of individual residues to the formation of this interface has not yet been studied extensively (Frick et al., 1992; Gronenborn and Clore, 1993; Walker et al., 1995) . The engineered reporter groups presented here are particularly useful for the quantitation of interface mutants (Sloan and Hellinga, manuscript in preparation).
Materials and methods

Calculations
Calculations of static solvent-accessible areas (Richards, 1977) were carried out on a NeXT work-station, implemented as part of the DEZYMER protein design program (Hellinga and Richards, 1991) . Molecular drawings were produced using MOLSCRIPT (Krollis, 1991) . Mutagenesis The variant of the gene for the B1 domain of Streptococcal protein G (GB1) used in this study contains a Met1Thr mutation that prevents N-terminal heterogeneity due to partial cleavage of the N-terminal methionine in the protein produced by over-expression in E.coli (Minor and Kim, 1994) . The gene from plasmid pGB1 was recloned into M13mp18, and single cysteine mutations were introduced by oligonucleotide-directed mutagenesis of uracil-containing single-stranded DNA (Kunkel, 1985) using oligonucleotides complementary to the sequence around Thr25 (T25C, 5Ј-GAC TTT TTC TGC GCA AGC AGC ATC ACC; mutagenic codon is underlined), Gln32 (Q32C, 5Ј-GTC GTT AGC GTA GCA TTT GAA GAC TTC) and Asp36 (D36C, 5Ј-GTC AAC ACC GTT GCA GTT AGC GTA TTG). Mutations were identified by DNA sequencing. Mutant genes were recloned behind the strong, inducible tac promoter of the pKK223-2 expression vector (Pharmacia) by PCR amplification using a pair of oligonucleotides that introduced EcoRI restriction sites near the 3Ј-and 5Ј-ends of the GB1 gene, as well as a methionine at position -1 of the N-terminus (5Ј-CGC GAA TTC ATG ACT ACT TAC AAA TTA ATC CTT AAT GGT AAA; restriction site in italics, Met codon underlined) and a pentahistidine Cterminal fusion (5Ј-CCG AAT TCA ACG TTA GTG ATG ATG GTG ATG TTC AGT AAC TGT AAA GGT CTT AGT CGC ATC; C-terminal histidine codons underlined, stop codon in bold face) to allow purification by immobilized metal affinity chromatography (IMAC) (Hochuli et al., 1988) . The entire GB1 gene sequence was verified by DNA sequencing of each expression construct. Protein expression and purification A colony of E.coli XL1-Blue cells (Stratagene), freshly transformed with an expression construct, was grown overnight at 37°C in 20 ml 2ϫYT medium containing 100 µg/ml ampicillin. This culture was used to inoculate 2 l 2ϫYT supplemented with 0.2% (w/v) glucose and grown at 37°C with vigorous shaking until an OD 600 of 0.6. Protein expression was induced by addition IPTG to 1 mM, followed by further growth for an 820 additional 4 h. Cells were harvested by centrifugation at 3000 g (20 min), resuspended in 60 ml high salt buffer (HSB: 50 mM phosphate, pH 7.0, 1 M NaCl) and stored frozen at -80°C. The cells were thawed and lysed in a chilled French press at 20 000 p.s.i. Cellular debris was removed by centrifugation at 6000 g for 20 min. Nucleic acids were precipitated by addition of polyenimine (pH 8.0) to 5% (w/v) and removed by centrifugation at 10 000 g for 20 min. Mutant proteins were then purified in a single-step IMAC procedure (Hochuli et al., 1988) . The cleared lysate was diluted to 100 ml with HSB, loaded onto a 75 ml iminodiacetate/zinc column (Pharmacia) and washed with 90 ml HSB to remove unbound proteins, followed by elution of the mutant protein using a 180 ml, 0-100 mM imidazole gradient in HSB. GB1 variants were located in a single late peak that revealed only one protein band on an overloaded 15% SDS/polyacrylamide gel stained with Coomassie blue. Yields typically were 15 mg/l growth. Fluorophore coupling Fully reduced, metal-free GB1 cysteine mutants were prepared by overnight incubation of affinity-purified protein with 50 mM EDTA, 2 mM o-phenanthroline, 50 mM dithiothreitol, followed by separation of the protein from chelators and reductant by gel filtration using a 50 mL P-6 column (BioRad) and low salt buffer (LSB: 20 mM phosphate, pH 6.0) for column equilibration and elution. The free thiol content of the mutant proteins was determined spectrophotometrically using 5-5Ј-dithiobis(2-nitrobenzoic acid) (DTNB) (Riddles et al., 1983) [ε 412 (DTNB) ϭ 13.7 mM -1 cm -1 ; ε 280 (GB1) ϭ 9.5 mM -1 cm -1 , this study], and typically corresponded to 0.9-1.1 thiols per protein. 6-Acryloyl-2-dimethylaminonapthalene (acrylodan), 5-iodoacetamidofluorescein (IAF), 4-chloro-7-nitrobenz-2-oxa-1,3-diazole (NBD), N-((2-(iodoacetoxy)ethyl)-N-methyl)amino-7-nitrobenz-2-oxa-1,3-diazole (IANBD) were purchased from Molecular Probes and used without additional purification. The fluorophores were dissolved in acetonitrile and reacted overnight with the freshly purified cysteine mutants (5:1 molar ratio) in LSB. Labelled protein was separated from free fluorophore by gel filtration using a 10 ml PD-10 column (Pharmacia), equilibrated and eluted with LSB. The extent of coupling was measured both by determining the remaining free thiol concentration using DTNB, and by determining the ratio of absorbances of the mutant protein and fluorophore chromophores [ε 392 (acrylodan) ϭ 20 mM -1 cm -1 ; ε 420 (NBD) ϭ 13 mM -1 cm -1 ; ε 469 (IANB) ϭ 23 mM -1 cm -1 ). Coupling was always found to be greater than 95%.
Binding of GB1 conjugates to a human IgG Fc fragment
The interaction between fluorescent GB1 conjugates and an unlabelled, proteolytically prepared hFc fragment of human IgG (purchased from ICN Biomedicals) was determined by measuring the changes in fluorescence emission of the conjugated fluorophore that occur upon addition of hFc to a solution of GB1 conjugate. Fluorescence emission spectra [4 nm excitation slit width; λ ex (acrylodan) ϭ 392 nm; λ ex (NBD) ϭ 420 nm; λ ex (IANB) ϭ 469 nm; λ ex (IAF) ϭ 493 nm] were recorded by addition of saturating amounts (4 µM) of hFc to a 200 nM solution of GB1 conjugates in LSB. For those GB1 conjugates that exhibited an appreciable change in fluorescence upon addition of saturating concentrations of hFc, the binding constant of the interaction of GB1 with the hFc fragment was determined by measuring the change in fluorescence emission at a wavelength that showed maximal change between the free and bound forms as a consequence of the direct titration with hFc of a 200 nM fluorophore-conjugated GB1 solution in LSB [16 nm emission slit width; λ em (acrylodan) ϭ 500 nm; λ em (NBD) ϭ 540 nm; λ em (IANB) ϭ 540 nm; λ em (IAF) ϭ 520 nm]. After each addition of hFc, the solution was allowed to equilibrate until a steady fluorescence emission signal was observed (typically a 30 s delay). The results were fit to an isotherm describing binding to a single site:
where ∆F is the change in fluorescence, ∆F max the fluorescence at saturation, S the concentration of hFc, and K d the dissociation constant.
Results
Identification of fluorophore attachment positions
The high-resolution structure of the complex between GB1 and hFc (Sauer-Eriksson et al., 1995) was analyzed by inspection ( Figure 1) and by calculating the static solvent-accessible surface area (SASA) (Richards, 1977) of the GB1 domain in the presence and absence of the bound IgG. This showed that three residues on the α-helix (Thr25, Gln32 and Asp36) are located at the rim of a surface patch of GB1 that forms the interface with the IgG. The SASA of Thr25 and Gln32 decreases by 35 and 65 Å 2 respectively upon complex formation, indicating that these two residues become partially buried, whereas Asp36 shows no such change. Most other residues that form the interface become completely buried in the complex. We therefore argued that positions 25, 32 and 36 are good potential sites for attachment of environmentally sensitive fluorophores to monitor complex formation without significant steric interference, because they are located in the vicinity of the interface, yet do not make extensive contacts with the bound IgG.
To test this hypothesis, single cysteine mutations were constructed by oligonucleotide-directed mutagenesis at each of these three sites. A panel of four thiol-reactive, environmentally sensitive fluorophores was attached at each of these positions. The fluorescent response resulting from the formation of the complex with an IgG fragment was tested for each of the twelve conjugates.
Binding behavior of fluorescent conjugates
Using a small change in the intrinsic tryptophan fluorescence of a hFc fragment, it had been established previously that the binding constant for the interaction of this fragment with GB1 is 306 nM (Walker et al., 1995) . To test the behavior of the engineered conjugates, the fluorescence emission spectra of a 200 nM solution of each of the conjugates were measured in the absence and presence of saturating amounts (4 µM) of hFc. Once a change in fluorescence had been established for a particular conjugate (Figure 2, inset A) , the binding constant was determined by recording the change in fluorescence emission, at an appropriate wavelength, upon step-wise addition of hFc to a 200 nM solution of fluorescent GB1 conjugate (Figure 2) . The resulting curves were analyzed by fitting to a standard binding isotherm (Equation 1). These results are summarized in Table I .
It was found that none of the conjugates at position 36 show a change in fluorescence upon addition of the hFc fragment. However, several conjugates at positions 25 and 32 exhibit significant changes, showing that the original design strategy can successfully identify locations to position reporter groups. The calculated SASA of position 36 shows no change upon 
a Ratio of the final to the initial fluorescence.
complex formation, whereas positions 25 and 32 do change. Some degree of interaction of the original side-chains is therefore necessary in order to ensure a change in the microenvironment of the attached fluorophore.
Even for the two sites where reporter groups can be attached successfully, the changes in fluorescence are highly dependent on the nature of the fluorophore and the attachment position. IAF shows no significant change at any position. IANBD shows an approximate doubling of fluorescence at both sites. NBD which has the same fluorophore as IANBD, but differs in the length of the spacer group and functional group to form the thiol-specific attachment, shows a modest fluorescent decrease at position 32, and a two-fold increase at position 25. Acrylodan is the most effective reporter group, showing significant increases at both positions. Further differences between the fluorophores can be observed in their effect on the binding constant. In all cases where IANBD and NBD give a response, the binding constant is approximately double that determined in the absence of the fluorophore by measuring changes in intrinsic tryptophan fluorescence, indicating that there is a small, but significant steric hindrance effect in the formation of the protein-protein interface upon introduction of these fluorophores. Interestingly, placement of acrylodan at position 25 results in a two-fold lowering of the binding constant, suggesting that the conjugated acrylodan contributes favorably to the formation of the complex, perhaps by providing a slightly larger hydrophobic surface area in the interface. Attachment of acrylodan at position 32 does not significantly affect the binding constant. This position therefore best satisfies the original design requirements: it shows a sufficiently large change in fluorescence upon complex formation (two-fold increase) for accurate determination of a binding constant, yet does not interfere significantly with formation of the natural interface. Microenvironment of the fluorophore conjugates Acrylodan and IANBD are sensitive to changes in the polarity of their microenvironment (Ghosh and Whitehouse, 1968; Weber and Farris, 1979; Macgregor and Weber, 1986) , which may result from changes in solvent accessibility, probe mobility, or steric interactions with the surrounding protein. The emission spectra of acrylodan are known to be particularly dependent on the polarity of the environment, showing a significant blue 822 shift in nonpolar relative to aqueous environments (Weber and Farris, 1979; Macgregor and Weber, 1986) . The emission spectra of the acrylodan conjugates at positions 25 and 32 show maxima at 500 and 520 nm (Figure 2) , suggesting that the attached acrylodan is present in two distinct environments differing in their polarities which are intermediate between ethanol and water, based on their blue shifts relative to water (Prendergast et al., 1983) . In the uncomplexed B1 domain, the 520 nm peak, corresponding to the more hydrophilic environment, dominates, whereas the 500 nm peak is the more prominent of the two in the complex, consistent with the acrylodan becoming more buried within the protein-protein interface.
To further characterize changes in the accessibility of the fluorophore, static quenching of the fluorescence of the GB1 conjugates was determined by measuring the variation in emission intensity with addition of iodide either to free proteins or the hFc complex. Iodide selectively quenches solventexposed fluorophores. The degree of quenching was analyzed using the Stern-Volmer law that describes steady-state collisional quenching (Lehrer and Leavis, 1978) :
where F/F 0 is the fractional decrease, [I -] the iodide concentration and K Q the quenching constant. K Q is dependent on the degree of accessibility of the fluorophore to the quencher, which in turn is correlated to the solvent accessibility. The degree of quenching of the acrylodan conjugate placed at position 32 decreases six-fold upon formation of the complex with hFc (Figure 2, inset B) , consistent with partial burial of the acrylodan within the protein-protein interface. The other conjugates showed a similar behavior (Table I) , but with smaller changes.
Discussion
We have devised a structure-based design strategy for placement of environmentally sensitive fluorophores in a proteinprotein interface such that complex formation is readily monitored without disrupting the natural protein-protein contacts. The high-resolution X-ray structure of the complex between the GB1 domain and hFc was used to identify residues in GB1, which are located on the rim of a surface patch that forms the interface with the hFc. Mere proximity to the interface is not sufficient, as was demonstrated by the lack of change in the signal of fluorophores attached to position 36. Instead, it is necessary to use residues which themselves are partially involved in formation of the complex. These are readily identifiable by calculating changes in the static solventaccessible surface area of residues upon complex formation. Quenching studies showed that sensing of complex formation involves a change in the solvent-accessibility of the attached fluorophore.
This approach should be readily extendable to other systems for which high-resolution structures of the complexes are available. Such engineered fluorophores are particularly useful to rapidly analyze binding constants of a series of interface mutants (Sloan and Hellinga, manuscript in preparation). They may also prove to find utility in the construction of fluorescent biosensors which monitor the formation of protein-protein interactions in complex mixtures.
